logo
Select company
Select metric
$ -21.19MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
20
Sector
48
Industry
64
History
88
$ 4.39Close
$ 3.62 - $ 6.75 52-Week Range
Ticker Information

Ticker

PLUR

Company Name

PLURI INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PLURI INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLUR - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 316K$ -21.51M$ -21.19M
3/31/2025$ 266K$ -21.54M$ -21.27M
12/31/2024$ 255K$ -20.68M$ -20.42M
9/30/2024$ 251K$ -22.62M$ -22.37M
6/30/2024$ 253K$ -21.7M$ -21.45M
3/31/2024$ 269K$ -19.95M$ -19.68M
12/31/2023$ 296K$ -22.28M$ -21.99M
9/30/2023$ 329K$ -25.5M$ -25.17M
6/30/2023$ 362K$ -26.68M$ -26.32M
3/31/2023$ 423K$ -30.88M$ -30.46M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PLURI INC's latest trailing twelve months (TTM) EBITDA stands at $ -29.57M.
  • Over the past 5 years, PLURI INC's average EBITDA has been $ -32.17M.
  • The median EBITDA for PLURI INC during this period was $ -30.02M
  • PLURI INC reached its highest EBITDA over the past 5 years at $ -19.68M.
  • The lowest EBITDA recorded by PLURI INC in the same timeframe $ -51.95M

PLURI INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
RANI : RANI THERAPEUTICS HOLDINGS INC $ -22.1MIGC : IGC PHARMA INC $ -5.75MCLSD : CLEARSIDE BIOMEDICAL INC $ -26.67MDTIL : PRECISION BIOSCIENCES INC $ -73.73MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.31MLSTA : LISATA THERAPEUTICS INC $ -19.71MADVM : ADVERUM BIOTECHNOLOGIES INC $ -160.41MRNXT : RENOVORX INC $ -11MCLNN : CLENE INC $ -24.75MRLYB : RALLYBIO CORP $ -41.54M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for PLURI INC is calculated as follows: EBIT [ $ -31.02M ] + DepAmor [ $ 1.45M ]
(=) EBITDA [ $ -29.57M ]

PLUR - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -51.95M

Minimum

Sep 30, 2021

$ -19.68M

Maximum

Mar 31, 2024

$ -32.17M

Average

$ -30.02M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M